NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000037771

Registered date:22/08/2019

Development of neo-self antibody research for recurrent pregnancy loss and obstetric complications

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedRecurrent pregnancy loss, obstetric complications, sterility
Date of first enrollment2019/08/01
Target sample size1200
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeA caste-control study evaluate whether beta2GPI/HLA-DR7 antibody is associated with recurrent pregnancy loss, obstetric complications, or sterility
Secondary OutcomeA cohort study for pregnant women (<21GW) evaluate whether beta2GPI/HLA-DR7 antibody is associated with obstetric complications

Key inclusion & exclusion criteria

Age minimum18years-old
Age maximum45years-old
GenderFemale
Include criteria
Exclude criteria1) Less than 18 years, or more than 45 years old 2) Inappropriate subjects 3) Multiple pregnancy or pregnancy with fetal anomaly

Related Information

Contact

public contact
Name Kenji Tanimura
Address 7-5-1 Kusunoki-cho Chuo-ku, Kobe, Japan Japan 650-0017
Telephone 0783826000
E-mail taniken@med.kobe-u.ac.jp
Affiliation Kobe University Graduate School of Medicine Department of Obstetrics & Gynecology
scientific contact
Name Hideto Yamada
Address 7-5-1 Kusunoki-cho Chuo-ku, Kobe, Japan Japan
Telephone 0783826000
E-mail yhideto@med.kobe-u.ac.jp
Affiliation Kobe University Graduate School of Medicine Department of Obstetrics & Gynecology